Cure Vac Appoints Axel Sven Malkomes As Chief Financial Officer
11/04/24, 3:05 PM
Location
tübingenIndustry
biotechnology
health care
Position
chief financial officer
CureVac appoints Axel Sven Malkomes as the new Chief Financial Officer, leveraging his extensive senior corporate and investment banking experience in the biotech and pharmaceutical industries.
Company Info
Location
tübingen, baden-württemberg, germany
Additional Info
CureVac N.V. is a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA). CureVac has more than 20 years of expertise in developing, optimizing, and manufacturing mRNA for medical purposes. The company focuses on using optimized mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.